Yesterday, according to report, Waldencast, the parent company of Milk Makeup and Obagi Medical, is expanding into the aesthetics market with the acquisition of Novaestiq Corp. and the U.S. rights to the Saypha line of hyaluronic acid injectable gels. The move marks Waldencast’s entry into the dermal filler space and a significant expansion of the Obagi brand beyond topical skincare.
The acquisition, which will operate under the Obagi Medical banner, reflects Waldencast’s strategy to transform Obagi into a comprehensive aesthetics platform. “We are excited to further diversify Obagi Medical’s portfolio of medical-grade skin care with consumer-centric, in-office injectable procedures,” said Michel Brousset, cofounder and CEO of Waldencast. “Adding proven products into our portfolio increases our addressable market and allows us to deliver solutions for professionals and patients seeking both skin care and aesthetic treatments, all under the trusted Obagi Medical brand.”
Saypha, developed by Austrian firm Croma-Pharma GmbH and available in over 80 countries, is currently undergoing FDA review for U.S. approval. The filler is formulated using a proprietary 3D matrix HA technology designed to deliver natural-looking results with a well-balanced gel texture.
Dr. Suzan Obagi, chief medical director at Obagi Medical, emphasized the synergy between Obagi’s skincare and injectable offerings: “By combining Obagi Medical skin care with injectable procedures under the guidance of a qualified professional, patients can achieve more significant, longer-lasting, and natural-looking results.”
Rather than spinning off the acquisition as a separate entity, Waldencast chose to integrate it fully under the Obagi name. “The Obagi brand is actually a big part of what is going to boost the performance of this business,” Brousset explained. “Our vision is to create Obagi as a mega brand in the world of beauty aesthetics.”
With this move, Waldencast signals its broader ambitions in aesthetics, with Brousset confirming that additional M&A activity in the space is likely. “This is our first step into aesthetics. We expect to have more steps in the future,” he said.
